1
|
Wong CX, Sun MT, Lau DH, Brooks AG,
Sullivan T, Worthley MI, Roberts-Thomson KC and Sanders P:
Nationwide trends in the incidence of acute myocardial infarction
in Australia, 1993-2010. Am J Cardiol. 112:169–173. 2013.PubMed/NCBI View Article : Google Scholar
|
2
|
Kramarow E, Lubitz J and Francis R Jr:
Trends in the coronary heart disease risk profile of middle-aged
adults. Ann Epidemiol. 23:31–34. 2013.PubMed/NCBI View Article : Google Scholar
|
3
|
Braga JR, Tu JV, Austin PC, Chong A, You
JJ, Farkouh ME, Ross HJ and Lee DS: Outcomes and care of patients
with acute heart failure syndromes and cardiac troponin elevation.
Circ Heart Fail. 6:193–202. 2013.PubMed/NCBI View Article : Google Scholar
|
4
|
Neri M, Riezzo I, Pascale N, Pomara C and
Turillazzi E: Ischemia/reperfusion injury following acute
myocardial infarction: A critical issue for clinicians and forensic
pathologists. Mediators Inflamm. 4(7018393)2017.PubMed/NCBI View Article : Google Scholar
|
5
|
Portt L, Norman G, Clapp C, Greenwood M
and Greenwood MT: Anti-apoptosis and cell survival: A review.
Biochim Biophys Acta. 1813:238–259. 2011.PubMed/NCBI View Article : Google Scholar
|
6
|
Wei Q, Yin Y, Xi M, Zhou D, Zhu Y, Guan Y,
Guo C, Wang Y, Duan J and Wen A: Antioxidant properties of
magnesium lithospermate B contribute to the cardioprotection
against myocardial ischemia/reperfusion injury in vivo and in
vitro. J Tradit Chin Med. 33:85–91. 2013.PubMed/NCBI View Article : Google Scholar
|
7
|
Wang Y, Zhang ZZ, Wu Y, Zhan J, He XH and
Wang YL: Honokiol protects rat hearts against myocardial ischemia
reperfusion injury by reducing oxidative stress and inflammation.
Exp Ther Med. 5:315–319. 2013.PubMed/NCBI View Article : Google Scholar
|
8
|
Wang L, Ma YT, Xie X, Yang YN, Fu ZY, Li
XM, Liu F, Huang Y, Ma X, Chen BD, et al: Interaction between MMP-9
gene polymorphisms and smoking in relation to myocardial infarction
in a Uighur population. Clin Appl Thromb Hemost. 18:72–78.
2012.PubMed/NCBI View Article : Google Scholar
|
9
|
Sinha R, Srivastava S, Joshi A, Joshi UJ
and Govil G: In-vitro anti-proliferative and anti-oxidant activity
of galangin, fisetin and quercet in: Role of localization and
intermolecular interaction in model membrane. Eur J Med Chem.
79:102–109. 2014.PubMed/NCBI View Article : Google Scholar
|
10
|
Chen PY, Ho YR, Wu MJ, Huang SP, Chen PK,
Tai MH, Ho CT and Yen JH: Cytoprotective effects of fisetin against
hypoxia-induced cell death in PC12 cells. Food Funct. 6:287–296.
2014.PubMed/NCBI View Article : Google Scholar
|
11
|
Pasparakis M: Regulation of tissue
homeostasis by NF-kappaB signalling: Implications for inflammatory
diseases. Nat Rev Immunol. 9:778–788. 2009.PubMed/NCBI View
Article : Google Scholar
|
12
|
Li JL, Chen XL and Sheng LP: Research of
the latest brain injury and MMP-9. J Gen Pract. 271–272. 2011.
|
13
|
Wagner DR, Delagardelle C, Ernens I, Rouy
D, Vaillant M and Beissel J: Matrix metalloproteinase-9 is a marker
of heart failure after acute myocardial infarction. J Card Fail.
12:66–72. 2006.PubMed/NCBI View Article : Google Scholar
|
14
|
Nićiforović N, Mihailović V, Masković P,
Solujić S, Stojković A and Pavlović Muratspahić D: Antioxidant
activity of selected plant species; potential new sources of
natural antioxidants. Food Chem Toxicol. 48:3125–3130.
2010.PubMed/NCBI View Article : Google Scholar
|
15
|
Valianou L, Stathopoulou K, Karapanagiotis
I, Magiatis P, Pavlidou E, Skaltsounis AL and Chryssoulakis Y:
Phytochemical analysis of young fustic (Cotinus coggygria
heartwood) and identification of isolated colourants in historical
textiles. Anal Bioanal Chem. 394:871–882. 2009.PubMed/NCBI View Article : Google Scholar
|
16
|
Savikin K, Zdunic G, Jankovic T,
Stanojkovic T, Juranic Z and Menkovic N: In vitro cytotoxic and
antioxidative activity of Cornus mas and Cotinus coggygria. Nat
Prod Res. 23:1731–1739. 2009.PubMed/NCBI View Article : Google Scholar
|
17
|
Tripathi R, Samadder T, Gupta S, Surolia A
and Shaha C: Anticancer activity of a combination of Cisplatin and
fisetin in embryonal carcinoma cells and xenograft tumors. Mol
Cancer Ther. 10:255–268. 2011.PubMed/NCBI View Article : Google Scholar
|
18
|
Cui EX, Long LH, Zhang JQ, Shao HY and Liu
LL: Extracorporeal anticoagulant and dissolving thrombus effects of
Fisetin and Quercetin. J Chin Med Mat. 32:1111–1113. 2009.(In
Chinese).
|
19
|
Park HH, Lee S, Oh JM, Lee MS, Yoon KH,
Park BH, Kim JW, Song H and Kim SH: Anti-inflammatory activity of
fisetin in human mast cells (HMC-1). Pharmacol Res. 55:31–37.
2007.PubMed/NCBI View Article : Google Scholar
|
20
|
Sengupta B, Banerjee A and Sengupta PK:
Interactions of the plant flavonoid fisetin with macromolecular
targets: Insights from fluorescence spectroscopic studies. J
Photochem Photobiol B. 80:79–86. 2005.PubMed/NCBI View Article : Google Scholar
|
21
|
Ivanova D, Gerova D, Chervenkov T and
Yankova T: Polyphenols and antioxidant capacity of Bulgarian
medicinal plants. J Ethnopharmacol. 96:145–150. 2005.PubMed/NCBI View Article : Google Scholar
|
22
|
Sengupta B, Banerjee A and Sengupta PK:
Investigations on the binding and antioxidant properties of the
plant flavonoid fisetin in model biomembranes. FEBS Lett.
570:77–81. 2004.PubMed/NCBI View Article : Google Scholar
|
23
|
Yang Y and Qian ZY: Effect of crocetin on
platelet aggregation in rats. Chin J Nat Med. 5:374–378. 2007.
|
24
|
Cui EX, Long LH, Liu J and Cao YX:
Anti-coagulation of cotinus coggygria scop. J Chin Med Mat.
30:202–205. 2007.(In Chinese).
|
25
|
Mennander AA, Vuohelainen V, Aanismaa RS,
Narkilahti S, Paavonen T and Tarkka M: Sildenafil after cardiac
arrest and infarction; an experimental rat model. Scand Cardiovasc
J Suppl. 47:58–64. 2013.PubMed/NCBI View Article : Google Scholar
|
26
|
Jin J, Chen F, Wang Q, Qiu Y, Zhao L and
Guo Z: Inhibition of TNF-α by cyclophosphamide reduces myocardial
injury after ischemia-reperfusion. Ann Thorac Cardiovasc Surg.
19:24–29. 2013.PubMed/NCBI View Article : Google Scholar
|
27
|
Ding YF, Zhang MM and He RR: Ischemic
preconditioning reduces cardiomyocytic apoptosis in rabbit heart in
vivo. Sheng Li Xue Bao. 52:220–224. 2000.PubMed/NCBI(In Chinese).
|
28
|
Long LH, Cao YX, Ma Z and Liu J:
Anticoagulant, anti-aggregation and antithrombotic effects of a
novel hexapeptide. J Pharm Pharmacol. 63:1454–1461. 2011.PubMed/NCBI View Article : Google Scholar
|
29
|
Maulik N, Sasaki H, Addya S and Das DK:
Regulation of cardiomyocyte apoptosis by redox-sensitive
transcription factors. FEBS Lett. 485:7–12. 2000.PubMed/NCBI View Article : Google Scholar
|
30
|
Galang N, Sasaki H and Maulik N: Apoptotic
cell death during ischemia/reperfusion and its attenuation by
antioxidant therapy. Toxicol. 148:111–118. 2000.PubMed/NCBI View Article : Google Scholar
|
31
|
Gabai VL, Meriin AB, Yaglom JA, Wei JY,
Mosser DD and Sherman MY: Suppression of stress kinase JNK is
involved in HSP72-mediated protection of myogenic cells from
transient energy deprivation HSP72 alleviates the stewss-induced
inhibition of JNK dephosphorylation. J Biol Chem. 275:38088–38094.
2000.PubMed/NCBI View Article : Google Scholar
|
32
|
Yu-hui H, Yun F, Fen J and Xing L: Study
about cardiomyocyte apoptosis in myocardial ischemic-reperfusion
injury of rats and NF-κB p65, iNOS expression. Xi Bao Yu Fen Zi
Mian Yi Xue Za Zhi. 26:868–870. 2010.PubMed/NCBI(In Chinese).
|
33
|
Yang F, Zhao WL, Mi QY, Xie LP, Liu Z,
Zhang W, Li XZ, Huang Y and Ji Y: Assessment of myocardial
ischemia-reperfusion injury with two different staining methods.
Acta Univ Med Nanjing (Nat Sci). 29:1055–1058. 2009.
|
34
|
Fantinelli JC, Gonzalez Arbelaez LF, Perez
Nunez IA and Mosca SM: Protective effects of
N-(2-mercaptopropionyl)-glycine against ischemia-reperfusion injury
in hypertrophied hearts. Exp Mol Pathol. 94:277–284.
2013.PubMed/NCBI View Article : Google Scholar
|
35
|
Chen J, Petrov A, Yaniz-Galende E, Liang
L, de Haas HJ, Narula J and Hajjar RJ: The impact of pressure
overload on coronary vascular changes following myocardial
infarction in rats. Am J Physiol Heart Circ Physiol. 304:H719–H728.
2013.PubMed/NCBI View Article : Google Scholar
|
36
|
Cao Z, Ren D, Ha T, Liu L, Wang X,
Kalbfleisch J, Gao X, Kao R, Williams D and Li C: CpG-ODN, the TLR9
agonist, attenuates myocardial ischemia/reperfusion injury:
Involving activation of PI3K/Akt signaling. Biochim Biophys Acta.
1832:96–104. 2013.PubMed/NCBI View Article : Google Scholar
|
37
|
Bacaksiz A, Teker ME, Buyukpinarbasili N,
Inan O, Tasal A, Sonmez O, Erdogan E, Turfan M, Akdemir OC and
Ertas G: Does pantoprazole protect against reperfusion injury
following myocardial ischemia in rats? Eur Rev Med Pharmacol Sci.
17:269–275. 2013.PubMed/NCBI
|
38
|
Yu YP, Xu QQ, Zheng MZ and Wei EQ: Light
transmission measurement of focal ischemic cerebral infarction in
mice. Zhejiang Da Xue Xue Bao Yi Xue Ban. 31:91–93. 2002.PubMed/NCBI(In Chinese).
|
39
|
Kou YY, Zha XD, Li YF and Ge RL: The
antioxidative effect of Sanwei Tanxiang powder on rats' hearts
against myocardial ischemia and reperfusion injury. Zhong Yao Cai.
31:1013–1015. 2008.PubMed/NCBI(In Chinese).
|
40
|
Zhang Q, Rui X and Cai D: Protective
effect of Ginaton on rat liver microcirculation disturbance
following liver xenotransplantation. Zhonghua Yi Xue Za Zhi.
80:706–708. 2000.PubMed/NCBI(In Chinese).
|
41
|
Ashraf HS, Hussain I, Siddiqui AA, Ibrahim
MN and Khan MU: The outcome of living related kidney
transplantation with multiple renal arteries. Saudi J Kidney Dis
Transpl. 24:615–619. 2013.PubMed/NCBI View Article : Google Scholar
|
42
|
Burton TM, Lacey M, Liu F, Yu Y, Monsalvo
ML, Lang K and Sander S: One-year follow-up healthcare costs of
patients hospitalized for transient ischemic attack or ischemic
stroke and discharged with aspirin plus extended-release
dipyridamole or clopidogrel. J Med Econ. 15:1217–1225.
2012.PubMed/NCBI View Article : Google Scholar
|
43
|
Violi F, Basili S, Berger JS and Hiatt WR:
Antiplatelet therapy in peripheral artery disease. Handb Exp
Pharmacol. 547–563. 2012.PubMed/NCBI View Article : Google Scholar
|
44
|
Weber R, Brenck J and Diener HC:
Antiplatelet therapy in cerebrovascular disorders. Handb Exp
Pharmacol. 519–546. 2012.PubMed/NCBI View Article : Google Scholar
|
45
|
Horton S and Augustin S: Activated
clotting time (ACT). Methods Mol Biol. 992:155–167. 2013.PubMed/NCBI View Article : Google Scholar
|
46
|
Papayannis AC, Abdel-Karim AR, Mahmood A,
Rangan BV, Makke LB, Banerjee S and Brilakis ES: Association of
coronary lipid core plaque with intrastent thrombus formation: A
near-infrared spectroscopy and optical coherence tomography study.
Catheter Cardiovasc Interv. 81:488–493. 2013.PubMed/NCBI View Article : Google Scholar
|
47
|
Lv Y, Ren Y, Sun L, Wang S, Wei M and Jia
D: Protective effect of Na(+)/Ca (2+) exchange blocker KB-R7943 on
myocardial ischemia-reperfusion injury in hypercholesterolemic
rats. Cell Biochem Biophys. 66:357–363. 2013.PubMed/NCBI View Article : Google Scholar
|
48
|
Ueno H and Harrington WF:
Temperature-dependence of local melting in the myosin subfragment-2
region of the rigor cross-bridge. J Mol Biol. 190:59–68.
1986.PubMed/NCBI View Article : Google Scholar
|
49
|
Manchikanti L, Falco FJ, Benyamin RM,
Caraway DL, Kaye AD, Helm S II, Wargo BW, Hansen H, Parr AT, Singh
V, et al: Assessment of bleeding risk of interventional techniques:
A best evidence synthesis of practice patterns and perioperative
management of anticoagulant and antithrombotic therapy. Pain
Physician. 16 (2 Suppl):SE261–SE318. 2013.PubMed/NCBI
|
50
|
Vanstreels L, Molenberghs G and Voigt JU:
Secondary stroke prevention: Misguided by guidelines? Acta Cardiol.
67:431–438. 2012.PubMed/NCBI View Article : Google Scholar
|
51
|
Torres-Urrutia C, Guzmán L,
Schmeda-Hirschmann G, Moore-Carrasco R, Alarcón M, Astudillo L,
Gutierrez M, Carrasco G, Yuri JA, Aranda E and Palomo I:
Antiplatelet, anticoagulant, and fibrinolytic activity in vitro of
extracts from selected fruits and vegetables. Blood Coagul
Fibrinolysis. 22:197–205. 2011.PubMed/NCBI View Article : Google Scholar
|
52
|
Joffs C, Gunasinghe HR, Multani MM, Dorman
BH, Kratz JM, Crumbley AJ III, Crawford FA Jr and Spinale FG:
Cardiopulmonary bypass induces the synthesis and release of matrix
metalloproteinases. Ann Thorac Surg. 71:1518–1523. 2001.PubMed/NCBI View Article : Google Scholar
|
53
|
Wang HT, Wang SM, Yun TTS, G. H and Wang
ZZ: Effects of sindacom on the expressions of MMP-9 and myocardial
ischemia reperfusion injury of rats. J Chin Gerontol. 30:2619–2621.
2010.(In Chinese).
|
54
|
Lee JS, Lee JS, Cha KJ, Kim DE, Lee D,
Jung SY, Park ES and Kim IS: Fisetin protects H9c2 cardiomyoblast
cells against H2O2-induced apoptosis through
Akt and ERK1/2 signaling pathways. Mol Cell Toxicol. 14:183–192.
2018.
|
55
|
Kang KA, Piao MJ, Madduma Hewage SR, Ryu
YS, Oh MC, Kwon TK, Chae S and Hyun JW: Fisetin induces apoptosis
and endoplasmic reticulum stress in human non-small cell lung
cancer through inhibition of the MARK signaling pathway. Tumour
Biol. 37:9615–9624. 2016.PubMed/NCBI View Article : Google Scholar
|
56
|
Kim JA, Lee S, Kim DE, Kim M, Kwon BM and
Han CH: Fisetin, a dietary flavonoid, induces apoptosis of cancer
cells by inhibiting HSF1 activity through blocking its binding to
the hsp70 promoter. Carcinogenesis. 36:696–706. 2015.PubMed/NCBI View Article : Google Scholar
|
57
|
Kang KA, Piao MJ and Hyun JW: Fisetin
induces apoptosis in human nonsmall lung cancer cells via a
mitochondria-mediated pathway. In Vitro Cell Dev Biol Anim.
51:300–309. 2015.PubMed/NCBI View Article : Google Scholar
|